Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Regulatory News In Brief

This article was originally published in The Gray Sheet

Executive Summary

FDA tells small businesses how to qualify for discounted user fees. Agency plans September conference for industry on unique device identification proposed rule. More regulatory news.

You may also be interested in...



Sequestration Threat Looms For 2013 Health Care Spending

A report from Sen. Tom Harkin states that impending across-the-board cuts would lead to major NIH grants reduction, in addition to significant spending cuts for cancer and HIV screening.

Judge Orders FDA To Hand Over Whistleblower Surveillance Documents

In the latest turn of events for FDA, a federal judge has ordered the agency to hand over thousands of documents accumulated from monitoring employees’ communications.

FDA’s UDI Draft Rule Details Device Marking, Database Submission Mandates

The long-anticipated proposal maps out a unique device identifier system that FDA says will be crucial to the future of post-market safety surveillance, recall management and safety alerts. The effort also will help reduce medical errors and bring an array of other benefits, stakeholders say.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031454

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel